Structured evidence table for Passionflower Anxiety Meta-Analysis, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Passionflower Anxiety Meta-Analysis | These disturbances occur despite adequate opportunity and conditions for sleep [], and they result in general dissatisfaction with sleep quality and various daytime impairments. | 3 | Żełabowski Kacper (2025) | The Efficacy of Melatonergic Receptor Agonists Used in Clinical Practice in Insomnia Treatment: Melatonin, Tasimelteon, Ramelteon, Agomelatine, and Selected Herbs |
| Passionflower Anxiety Meta-Analysis | Individuals reporting nighttime symptoms without associated daytime dysfunction are not classified as having clinical insomnia [,]. | 3 | Żełabowski Kacper (2025) | The Efficacy of Melatonergic Receptor Agonists Used in Clinical Practice in Insomnia Treatment: Melatonin, Tasimelteon, Ramelteon, Agomelatine, and Selected Herbs |
| Passionflower Anxiety Meta-Analysis | Studies have demonstrated a direct correlation between inadequate sleep and an increased risk of developing metabolic diseases, such as diabetes, obesity, hypertension, cardiovascular disease, and depression [,,]. | 3 | Żełabowski Kacper (2025) | The Efficacy of Melatonergic Receptor Agonists Used in Clinical Practice in Insomnia Treatment: Melatonin, Tasimelteon, Ramelteon, Agomelatine, and Selected Herbs |
| Passionflower Anxiety Meta-Analysis | 1 2 2 3 4 3 5 6 6 4 6 The etymology of the term “insomnia” derives from Latin, combining “in” meaning “not” and “somnus,” meaning “sleep” []. | 3 | Żełabowski Kacper (2025) | The Efficacy of Melatonergic Receptor Agonists Used in Clinical Practice in Insomnia Treatment: Melatonin, Tasimelteon, Ramelteon, Agomelatine, and Selected Herbs |
Source documents